<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30344568</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">1682-024X</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>34</Volume>                    <Issue>5</Issue>                    <PubDate>                        <MedlineDate>2018 Sep-Oct</MedlineDate>                    </PubDate>                </JournalIssue>                <Title>Pakistan journal of medical sciences</Title>                <ISOAbbreviation>Pak J Med Sci</ISOAbbreviation>            </Journal>            <ArticleTitle>Association of <i>BRCA1 185 del AG</i> with early age onset of breast cancer patients in selected cohort from Pakistani population.</ArticleTitle>            <Pagination>                <MedlinePgn>1158-1163</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.12669/pjms.345.15764</ELocationID>            <Abstract>                <AbstractText Label="Background &amp; Objective" NlmCategory="UNASSIGNED">Large spectrum of pathogenic <i>BRCA</i> mutations is known as a major cause of hereditary breast ovarian cancer in human all over the world. The objective of present study was to find out the association of mutations<i>185-del-AG</i> and <i>185Ins.A</i> at <i>BRCA1</i> exon-2 with age of onset and family history of gynecological cancer among the selected cohort of breast cancer patients in Pakistani population and to provide guidelines for treatment strategies.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">For the present study 115 subjects were recruited from different hospitals of Punjab, Pakistan, during May, 2017 to February, 2018. The inclusion criteria were age â‰¥30, without any previous <i>BRCA</i> testing and willingness to participate in present study. Subjects were interviewed for various demographic factors. Out of 115 subjects, 46 were selected on the basis of findings of previous studies and approximately 3 ml of blood was collected in EDTA coated vials for analysis of BRCA1 exon-2. Column based DNA extraction was performed by using commercial kit and exon specific primers were used to amplify <i>BRCA1</i> exon 2 and PCR products were sent for sequencing to Eurofins Genomics. Sequences were analyzed through the BLAST program at National Center for Biotechnology Information (NCBI) and Bio Edit software. Accession numbers were obtained on submission of sequences in GenBank.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED"><i>BRCA1-185-del AG mutation was found in one of the breast cancer patient who was 33 years of age at diagnosis</i>. None of the samples revealed positive results for <i>BRCA1-185 Ins. A</i>.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED"><i>BRCA1-185 Del AG</i> mutation has association with early age onset of breast cancer. The direct sequencing is very useful approach for <i>BRCA</i> analysis and exon specific selected cohort from Pakistani population.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Durr-E-Samin</LastName>                    <AffiliationInfo>                        <Affiliation>Durr-e-Samin, Ph.D Candidate. Centre of Agriculture Biochemistry and Biotechnology, University of Agriculture, Faisalabad, Pakistan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Saif-Ur-Rehman</LastName>                    <ForeName>Muhammad</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Muhammad Saif-ur-Rehman, Ph.D. Institute of Animal and Dairy Sciences, University of Agriculture, Faisalabad, Pakistan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shahnawaz-Ul-Rehman</LastName>                    <ForeName>Muhammad</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Muhammad Shahnawaz-ul-Rehman, Ph.D. Centre of Agriculture Biochemistry and Biotechnology, University of Agriculture, Faisalabad, Pakistan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Khan</LastName>                    <ForeName>Muhammad Sajjad</ForeName>                    <Initials>MS</Initials>                    <AffiliationInfo>                        <Affiliation>Muhammad Sajjad Khan, Ph.D. Institute of Animal and Dairy Sciences, University of Agriculture, Faisalabad, Pakistan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Pakistan</Country>            <MedlineTA>Pak J Med Sci</MedlineTA>            <NlmUniqueID>100913117</NlmUniqueID>            <ISSNLinking>1681-715X</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2013 Jan 10;31(2):210-6</RefSource>                <PMID Version="1">23233716</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2016;17(4):1725-7</RefSource>                <PMID Version="1">27221844</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65</RefSource>                <PMID Version="1">12237281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2002 Jan 25;108(2):171-82</RefSource>                <PMID Version="1">11832208</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Hum Genet. 2002 Sep;71(3):595-606</RefSource>                <PMID Version="1">12181777</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Intern Med. 2012 Apr;271(4):331-43</RefSource>                <PMID Version="1">22443199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1994 Oct 7;266(5182):66-71</RefSource>                <PMID Version="1">7545954</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Oncol. 2011;2011:632870</RefSource>                <PMID Version="1">21559243</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2006 Dec 15;119(12):2832-9</RefSource>                <PMID Version="1">16998791</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2016 Aug 1;126(8):2903-18</RefSource>                <PMID Version="1">27454287</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gynecol Oncol. 2015 Apr;26(2):156-67</RefSource>                <PMID Version="1">25872896</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2015 May;137(2):343-50</RefSource>                <PMID Version="1">25725131</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Mutat. 2006 Oct;27(10):1024-9</RefSource>                <PMID Version="1">16941470</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2007 Jun;18 Suppl 6:vi93-8</RefSource>                <PMID Version="1">17591843</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Mutat. 2016 Dec;37(12):1318-1328</RefSource>                <PMID Version="1">27633797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2006 Mar 06;34(5):1416-26</RefSource>                <PMID Version="1">16522651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Semin Surg Oncol. 2008 Aug 29;5:21</RefSource>                <PMID Version="1">18759965</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 May 1;136(9):1991-2000</RefSource>                <PMID Version="1">24615680</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Coll Physicians Surg Pak. 2011 Nov;21(11):680-4</RefSource>                <PMID Version="1">22078348</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Thorac Dis. 2013 Jun;5 Suppl 1:S2-8</RefSource>                <PMID Version="1">23819024</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 1996 Oct;14(2):185-7</RefSource>                <PMID Version="1">8841191</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">185 Ins. A</Keyword>            <Keyword MajorTopicYN="N">185-Del-AG</Keyword>            <Keyword MajorTopicYN="N">BRCA1</Keyword>            <Keyword MajorTopicYN="N">Breast Cancer</Keyword>            <Keyword MajorTopicYN="N">Exon-2</Keyword>            <Keyword MajorTopicYN="N">Pakistani population</Keyword>        </KeywordList>        <CoiStatement>Conflict of Interests: The authors have no conflict of interests.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30344568</ArticleId>            <ArticleId IdType="doi">10.12669/pjms.345.15764</ArticleId>            <ArticleId IdType="pii">PJMS-34-1158</ArticleId>            <ArticleId IdType="pmc">PMC6191806</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>